A compound of the formula (I): R.sup.1--NH--X--Y-Z (I) wherein each symbol is as defined in the specification, or a pharmaceutically acceptable salt thereof useful as a vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, a method for preventing or treating a VAP-1 associated disease, especially macular edema, which method includes administering an effective amount of the compound or a pharmaceutically acceptable salt thereof to a mammal, and the like.

 
Web www.patentalert.com

< Cycloalkyl-Hydroxyl Compounds and Compositions for Cholesterol Management and Related Uses

< CETP inhibitors in combination with antihypertensive agents and uses thereof

> Substituted pyrirmidin-4-ylamine analogues as vanilloid receptor ligands

> Opioid receptor active compounds
~ 00270